Literature DB >> 6342508

Intracerebral hemorrhage and vasculitis related to ephedrine abuse.

M R Wooten, M S Khangure, M J Murphy.   

Abstract

Intracerebral hemorrhage occurred in a 20-year-old man following self-administration of ephedrine. Changes seen on cerebral angiography were typical of vasculitis, and immune complex deposition was found in a skin biopsy. This combination has not previously been reported with ephedrine abuse although it is well known with amphetamine abuse.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342508     DOI: 10.1002/ana.410130321

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Coronary thrombosis related to use of Xenadrine RFA.

Authors:  Rajesh Sachdeva; Satish Sivasankaran; Robert F Fishman; Stuart W Zarich; Craig A McPherson
Journal:  Tex Heart Inst J       Date:  2005

Review 2.  Central nervous system stimulants and sport practice.

Authors:  L Avois; N Robinson; C Saudan; N Baume; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

3.  Necrotising vasculitis of the skin associated with an herbal medicine containing amfepramone.

Authors:  Ulrike Halbsguth; Stefanie Schwanda; Thomas Lehmann; Sonja Ostheeren-Michaelis; Karin Fattinger
Journal:  Eur J Clin Pharmacol       Date:  2009-03-05       Impact factor: 2.953

Review 4.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

Review 5.  Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.

Authors:  Arthur N Westover; Ethan A Halm
Journal:  BMC Cardiovasc Disord       Date:  2012-06-09       Impact factor: 2.298

6.  Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard.

Authors:  Katherine Esse; Marco Fossati-Bellani; Angela Traylor; Sheryl Martin-Schild
Journal:  Brain Behav       Date:  2011-09       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.